Hrab et al. investigated 89 patients with renal cell carcinoma (mean age 60 years (range 30–81)), and found that elevated preoperative plasma level of CRP was also correlated with impaired overall survival and disease-specific survival within 6 years after surgery. Here, CRP is linked to renal cell carcinoma.